Robertson Scott M.'s Form 4 filing
DICE Therapeutics, Inc. (DICE) · filed May 5, 2023
- Accession no.
- 0001209191-23-027790
- Filed
- May 5, 2023
- Trade date
- May 3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $685.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robertson Scott M.CIK 0001882035 | Officer (CFO & CBO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | Common Stock | SSaleDisposed | −18,750 | $36.55 | −$685,312.5 | 198,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.